(Q44092149)

English

SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

Olivier Cottencin

object named as

Olivier Cottencin

5

0 references

Pierre-Michel Llorca

3

object named as

Pierre Michel Llorca

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Guillaume Vaiva

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pierre Thomas

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sylvie Dupont

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Patrick Devos

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Olivier Mazas

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Claire Rascle

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Marc Steinling

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Michel Goudemand

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Psychiatry Research

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

37-48

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Treatment of negative symptoms in schizophrenia with amisulpride

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Information processing and attention dysfunctions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amisulpride: a review of its use in the management of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Active and remitted schizophrenia: psychopathological and regional cerebral blood flow findings

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropsychological heterogeneity in schizophrenia: a consideration of abstraction and problem-solving abilities

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: a single photon emission-computed tomography and auditory evoked potentials study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of sulpiride on negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional cerebral blood flow in first-episode schizophrenia patients before and after antipsychotic drug treatment. Scottish Schizophrenia Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional cerebral blood flow in schizophrenia before and after neuroleptic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2802%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0925-4927(02)00031-8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44092149&oldid=2106511956"